期刊文献+

骨桥蛋白下调对乳腺癌细胞生物学行为及MMP-2表达的影响 被引量:2

Effect of downregulation of osteopontin on biological behaviors and MMP-2 expression of breast cancer cells
下载PDF
导出
摘要 目的:研究下调骨桥蛋白(osteopontin,OPN)对乳腺癌MDA-MB-231细胞生物学行为及基质金属蛋白酶-2(matrix metalloproteinase-2,MMP-2)表达的影响。方法:采用重组的OPN mRNA干扰质粒转染MDA-MB-231细胞,建立稳定转染细胞株。RT-PCR和Western印迹法检测细胞中OPN和MMP-2的表达,MTT法、流式细胞仪检测和软琼脂生长实验观察OPN下调对细胞生长、细胞周期分布和瘤细胞恶性表型的影响,酶联免疫吸附法(ELISA)检测细胞培养液中MMP-2的分泌水平。结果:与MDA-MB-231细胞相比,建立的转染细胞株M-OPNS1和M-OPNS2细胞的OPN mRNA及其蛋白表达均显著下调,细胞生长受到抑制,在细胞周期上表现为S期阻滞;OPN下调的细胞在软琼脂上的生长能力明显下降,MMP-2表达也明显降低。结论:RNA干扰介导的OPN下调能抑制MDA-MB-231细胞增殖、下调细胞恶性程度和MMP-2的表达,这可能为将来乳腺癌治疗提供新的方法。 Objective: To study the effects of downregulation of osteopontin (OPN) on biological behaviors and matrix metallo-proteinase-2 (MMP-2) expression of breast cancer cells MDA-MB-231. Methods: siRNA expression vectors were designed to target OPN and named as pSilence-OPN S 1 and pSilence-OPN S 2. The two plasmids were transfected into MDA-MB-231 cells. The mRNA and protein expression of OPN and MMP-2 were measured by RT-PCR and Western blotting, respectively. The effect of downregulation of OPN on cell proliferation, cell cycle distribution, and malignant phenotype of MDA-MB-231 cells were determined by MTT assay, flow cytometry, and soft agar assay, respectively. The level of MMP-2 protein in the supernatant of cultured cells was measured with ELISA. Results : The expression of OPN in the transfected cells ( M-OPN S 1 and M-OPN S 2) was significantly downregulated at both mRNA and protein levels compared with MDA-MB-231 cells. The proliferation of transfected cells was inhibited and the cells were arrested at S phase. Downregulation of OPN caused a significant reduction in colony formation rate and MMP-2 expression. Conclusions: The stable silencing of OPN gene expression with siRNA inhibited the proliferation of MDA-MB-231 cells, downregulats malignant degree and MMP-2 expression. It may provide a novel therapeutic approach for breast cancer therapy.
出处 《肿瘤》 CAS CSCD 北大核心 2007年第12期939-943,共5页 Tumor
基金 江苏省自然科学基金项目(编号:BK2005070)
关键词 乳腺肿瘤 骨桥蛋白 RNA 小分子干扰 表型 基质金属蛋白酶类 Breast neoplasms Osteopontin RNA,small interfering Phenotype Matrix metalloproteinases
  • 相关文献

参考文献15

  • 1EL-TANANI M K, CAMPBELL F C, KURISETTY V, et al. The regulation and role of osteopontin in malignant transformation and cancer[ J ]. Cytokine Growth Factor Rev, 2006, 17 (6) :463-474.
  • 2侯志波,郑杰.骨桥蛋白下调对前列腺癌PC3细胞生物学行为的影响[J].肿瘤,2005,25(6):542-546. 被引量:4
  • 3PAN H W, OU Y H, PENG S Y, et al. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma[J]. Catwer, 2003, 98( 1 ) :119-127.
  • 4HWANG H J, PARK H J, CHUNG H J, et al. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT 1080 fibrosarcoma cells[J]. J Nutr Biochem, 2006, 17 (5) :356-362.
  • 5ZHENG J, DENG Y P, LIN C, et al. Arsenic trioxide induces apoptosis of HPV 16 DNA -immortalized human cervical epithelial cells and inhibits viral gene expression[ J]. Int J Cancer, 1999, 82(2) :286-292.
  • 6BELLAHCENE A, CASTRONOVO V. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer[ J]. Am J Pathol, 1995,146( 1 ) :95-100.
  • 7BRAMWELL VH, DOIG GS, TUCK AB, et al. Serial plasma osteopontin levels have prognostic value in metastatic breast cancer [J]. Clin Cancer Res, 2006, 12(11 Pt 1 ) :3337-3343.
  • 8WANG-RODRIGUEZ J, URQUIDI V, RIVARD A, et al. Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status [J]. Breast Cancer Res, 2003, 5(5) :R136-143.
  • 9SHEVDE L A, SAMANT R S, PAIK J C,et al. Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435[J]. Clin Exp Metastasis, 2006, 23(2) :123- 133
  • 10UNNI E, KrrTRELL F S, SINGH U, et al. Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine [ J ]. Breast Cancer Res, 2004, 6 ( 5 ) : R586-592.

二级参考文献9

  • 1Behrend EI,Craig AM,Wilson SM,et al.Reduced malignancy of ras-transformed NIH/3T3 cells expressing antisense osteopontin RNA[J].Cancer Res,1994,54(3):832-837.
  • 2Muramatsu T,Shima K,Ohta K,et al.Inhibition of osteopontin expression and function in oral cancer cell lines by antisense oligonucleotides[J].Cancer Lett,2005,217(1):87-95.
  • 3Weber GF.The metastasis gene osteopontin:a candidate target for cancer therapy[J].Biochim Biophys Acta,2001,1552(2):61-85.
  • 4Reynold A,Leake D,Boese Q,et al.Rational siRNA design for RNA interference[J].Nat Biotechnol,2004,22(3):326-330.
  • 5Tuck AB,Chambers AF.The role of osteopontin in breast cancer:clinical and experimental studies[J]. J Mammary Gland Biol Neoplasia,2001,6(4):419-429.
  • 6Notterman DA,Alon U,Sierk AJ,et al.Transcriptional gene expression profiles of colorectal adenoma,adenocarcinoma,and normal tissue examined by oligonucleotide arrays[J].Cancer Res,2001,61(7):3124-3130.
  • 7Thalmann GN,Sikes PA,Devoll RE,et al.Osteopontin: possible role in prostate cancer progression[J].Clin Cancer Res,1999,5(8):2271-2277.
  • 8Sinha R,Medina D.Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells[J].Carcinogenesis,1997,18(8):1541-1547.
  • 9Wai PY,Kuo PC.The role of osteopontin in tumor metastasis[J]. J Surg Res,2004,121(2):228-241.

共引文献3

同被引文献6

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部